BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34418824)

  • 1. Risk factors for gastrostomy tube dependence in transoral robotic surgery patients.
    Philips R; Topf MC; Vimawala S; Luginbuhl A; Curry JM; Cognetti DM
    Am J Otolaryngol; 2022; 43(1):103175. PubMed ID: 34418824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma.
    Heah H; Goepfert RP; Hutcheson KA; Garden AS; Gunn GB; Fuller CD; Lewin JS; Kupferman ME; Holsinger FC; Hessel AC; Gross ND
    Head Neck; 2018 Nov; 40(11):2507-2513. PubMed ID: 30102824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
    Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feeding Tube Placement Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
    Feng AL; Holcomb AJ; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Holman A; Kammer RE; Goldsmith TA; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
    Otolaryngol Head Neck Surg; 2022 Apr; 166(4):696-703. PubMed ID: 34154449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage Transoral Robotic Surgery for Recurrent or Residual Head and Neck Squamous Cell Carcinoma: A Single Institution Experience.
    Dabas S; Dewan A; Ranjan R; Dewan AK; Shukla H; Sinha R
    Asian Pac J Cancer Prev; 2015; 16(17):7627-32. PubMed ID: 26625773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.
    Groysman M; Yi SK; Robbins JR; Hsu CC; Julian R; Bauman JE; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2022; 43(1):103243. PubMed ID: 34583290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
    Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
    Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of gastrostomy tube dependence in surgically managed oropharyngeal squamous cell carcinoma.
    Varma VR; Eskander A; Kang SY; Kumar B; Brown NV; Zhao S; Brock G; Agrawal A; Carrau RL; Old MO; Ozer E; Rocco JW; Schuller DE; Dziegielewski PT; Cipolla MJ; Teknos TN
    Laryngoscope; 2019 Feb; 129(2):415-421. PubMed ID: 30194767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Lörincz BB; Möckelmann N; Busch CJ; Knecht R
    Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasogastric tube feeding after transoral robotic surgery for oropharynx carcinoma.
    Plonowska KA; Ochoa E; Zebolsky AL; Patel N; Hoppe KR; Ha PK; Heaton CM; Ryan WR
    Am J Otolaryngol; 2021; 42(3):102857. PubMed ID: 33513477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy.
    Sharma A; Patel S; Baik FM; Mathison G; Pierce BH; Khariwala SS; Yueh B; Schwartz SM; Méndez E
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):691-7. PubMed ID: 27347780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
    Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
    J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
    Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
    Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma.
    Sinclair CF; McColloch NL; Carroll WR; Rosenthal EL; Desmond RA; Magnuson JS
    Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1112-6. PubMed ID: 22106235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
    Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Outcomes in Patients with Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Treated with Trimodality Therapy.
    Lu JS; Cao AC; Shimunov D; Sun L; Lukens JN; Lin A; Cohen RB; Basu D; Cannady SB; Rajasekaran K; Weinstein GS; Brody RM
    Laryngoscope; 2023 Nov; 133(11):3013-3020. PubMed ID: 37129315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Transoral Robotic Surgery With Short-term and Long-term Outcomes and Costs of Care in Oropharyngeal Cancer Surgery.
    Motz K; Chang HY; Quon H; Richmon J; Eisele DW; Gourin CG
    JAMA Otolaryngol Head Neck Surg; 2017 Jun; 143(6):580-588. PubMed ID: 28358930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients With Early-Stage Oropharyngeal Squamous Cell Carcinoma.
    Nguyen AT; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Shiao SL; Ho AS; Zumsteg ZS
    JAMA Oncol; 2020 Oct; 6(10):1555-1562. PubMed ID: 32816023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.